A study observed that anti-PD-1 therapy induces hyper-progression with clonal expansion of tumor-infiltrating Treg cells with upregulation of some genes, including CD177 and BCL2L1 in a leukemic patient [144], the two genes we found to be elevated specifically in tumor-infiltrating Treg cells. The gene discussed is BCL2L1; the disease is neoplasm.